deltatrials
Completed OBSERVATIONAL NCT01543477

Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO II)

POST-AUTHORISATION SAFETY COHORT OBSERVATION OF RETACRIT (EPOETIN ZETA) ADMINISTERED SUBCUTANEOUSLY FOR THE TREATMENT OF RENAL ANAEMIA (PASCO II)

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer

Conditions Lactation Pregnancy Renal Anemia
Updated 26 times since 2017 Last updated: Sep 29, 2020 Started: Jul 7, 2010 Primary completion: Apr 29, 2020 Completion: Apr 29, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lactation and Pregnancy, this trial is completed. The trial is conducted by Hospira, now a wholly owned subsidiary of Pfizer and has accumulated 26 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshot~Apr 2017 – ~Aug 2017 · 4 months · monthly snapshot~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshot~Jul 2019 – ~Nov 2019 · 4 months · monthly snapshot~Nov 2019 – ~Jul 2020 · 8 months · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

26 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Dec 2021 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Dec 2021 [monthly]

    Completed

▶ Show 21 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Completed

  2. Oct 2020 — Nov 2020 [monthly]

    Completed

  3. Jul 2020 — Oct 2020 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  4. Nov 2019 — Jul 2020 [monthly]

    Active Not Recruiting

  5. Jul 2019 — Nov 2019 [monthly]

    Active Not Recruiting

  6. Mar 2019 — Jul 2019 [monthly]

    Active Not Recruiting

  7. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting

  8. Dec 2018 — Feb 2019 [monthly]

    Active Not Recruiting

  9. Sep 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  10. Aug 2018 — Sep 2018 [monthly]

    Active Not Recruiting

  11. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  12. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting

  13. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  14. Mar 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  15. Feb 2018 — Mar 2018 [monthly]

    Recruiting NA

  16. Dec 2017 — Feb 2018 [monthly]

    Recruiting NA

  17. Aug 2017 — Dec 2017 [monthly]

    Recruiting NA

  18. Apr 2017 — Aug 2017 [monthly]

    Recruiting NA

  19. Mar 2017 — Apr 2017 [monthly]

    Recruiting NA

  20. Feb 2017 — Mar 2017 [monthly]

    Recruiting NA

  21. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hospira, now a wholly owned subsidiary of Pfizer
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Agioi Apostoloi, Greece , Agios Nikolaos, Crete, Greece , Agrinio, Greece , Aigáleo, Greece , Alexandroupoli, Greece , Alsfeld, Germany , Alzey, Germany , Amiens (Salouel) Cedex 1, France , Ancona, Italy and 129 more locations